FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ann Stewart

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Macaca mulatta

Procedures

Anatomy

Concepts & Ideas

Immunization Schedule

Physiology

Cellular Immunity

Co-author Network

Publications

TOP 3
James F Cummings; Michele D Spring; Robert Schwenk; Christian F Ockenhouse; Kent Kester; Mark E Polhemus; Douglas S Walsh; In-Kyu Yoon; Christine Prosperi; Laure Y Juompan; David Lanar; Urszula Krzych; B Ted Hall; Lisa A Ware; V Ann Stewart; Jack Williams; Megan G Dowler; Robin K Nielsen; Collette J Hillier; Birgitte K Giersing; Filip Dubovsky; Elissa Malkin; Kathryn Tucker; Marie-Claude Dubois; Joe D Cohen; W Ripley Ballou; Donald Heppner
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Sathit Pichyangkul; Pongsri Tongtawe; Utaiwan Kum-arb; Kosol Yongvanitchit; Montip Gettayacamin; M R Hollingdale; A Limsalakpetch; V Ann Stewart; David Lanar; S Dutta; Evelina Angov; L A Ware; Elke Bergmann-Leitner; B House; Gerald Voss; M C Dubois; Joe D Cohen; M M Fukuda; Donald Heppner; R Scott Miller
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.
Kent Kester; James F Cummings; Opokua Ofori-Anyinam; Christian F Ockenhouse; Urszula Krzych; Philippe Moris; Robert Schwenk; Robin A Nielsen; Zufan Debebe; Evgeny Pinelis; Laure Juompan; Jack Williams; Megan G Dowler; V Ann Stewart; Robert A Wirtz; Marie-Claude Dubois; Marc Lievens; Joe Cohen; W Ripley Ballou; Donald Heppner
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ann Stewart (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: James F Cummings; Michele D Spring; Robert Schwenk; Christian F Ockenhouse; Kent Kester; Mark E Polhemus; Douglas S Walsh; In-Kyu Yoon; Christine Prosperi; Laure Y Juompan; David Lanar; Urszula Krzych; B Ted Hall; Lisa A Ware; V Ann Stewart; Jack Williams; Megan G Dowler; Robin K Nielsen; Collette J Hillier; Birgitte K Giersing; Filip Dubovsky; Elissa Malkin; Kathryn Tucker; Marie-Claude Dubois; Joe D Cohen; W Ripley Ballou; Donald Heppner
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Vaccine 2010;28(31):5135-44.
2009: Sathit Pichyangkul; Pongsri Tongtawe; Utaiwan Kum-arb; Kosol Yongvanitchit; Montip Gettayacamin; M R Hollingdale; A Limsalakpetch; V Ann Stewart; David Lanar; S Dutta; Evelina Angov; L A Ware; Elke Bergmann-Leitner; B House; Gerald Voss; M C Dubois; Joe D Cohen; M M Fukuda; Donald Heppner; R Scott Miller
Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.
Vaccine 2009;28(2):452-62.
2009: Kent Kester; James F Cummings; Opokua Ofori-Anyinam; Christian F Ockenhouse; Urszula Krzych; Philippe Moris; Robert Schwenk; Robin A Nielsen; Zufan Debebe; Evgeny Pinelis; Laure Juompan; Jack Williams; Megan G Dowler; V Ann Stewart; Robert A Wirtz; Marie-Claude Dubois; Marc Lievens; Joe Cohen; W Ripley Ballou; Donald Heppner
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
The Journal of infectious diseases 2009;200(3):337-46.
2009: Bernhards R Ogutu; Odika J Apollo; Denise McKinney; Willis Okoth; Joram Siangla; Filip Dubovsky; Kathryn Tucker; John N Waitumbi; Carter L Diggs; Janet Wittes; Elissa Malkin; Amanda Leach; Lorraine A Soisson; Jessica B Milman; Lucas Otieno; Carolyn A Holland; Mark Polhemus; Shon A Remich; Christian F Ockenhouse; Joe Cohen; W Ripley Ballou; Samuel K Martin; Evelina Angov; V Ann Stewart; Jeffrey A Lyon; Donald Heppner; Mark R Withers
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
PloS one 2009;4(3):e4708.
2008: Joseph P Shott; Shannon M McGrath; Maria G Pau; Jerome H H V Custers; Olga Ophorst; Marie-Ange Demoitié; Marie-Claude Dubois; Jack Komisar; Michelle Cobb; Kent Kester; Patrice Dubois; Joe Cohen; Jaap Goudsmit; Donald Heppner; V Ann Stewart
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.
Vaccine 2008;26(23):2818-23.
2008: Carolyne M Kifude; G-Halli Rajasekariah; David Sullivan; V Ann Stewart; Evelina Angov; Samuel K Martin; Carter L Diggs; John N Waitumbi
Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum.
Clinical and vaccine immunology : CVI 2008;15(6):1012-8.
2008: Pascal Mettens; Patrice M Dubois; Marie-Ange Demoitié; Babak Bayat; Marie-Noëlle Donner; Patricia Bourguignon; V Ann Stewart; Donald Heppner; Nathalie Garçon; Joe Cohen
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.
Vaccine 2008;26(8):1072-82.
2008: V Ann Stewart; Shannon McGrath; Arthur M Krieg; Noelle S Larson; Evelina Angov; Christopher L Smith; Thomas G Brewer; Donald Heppner
Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaques.
Clinical and vaccine immunology : CVI 2008;15(2):221-6.
2008: Sathit Pichyangkul; Utaiwan Kum-arb; Kosol Yongvanitchit; A Limsalakpetch; Montip Gettayacamin; David Lanar; Lisa A Ware; V Ann Stewart; Donald Heppner; Pascal Mettens; Joe D Cohen; W Ripley Ballou; M M Fukuda
Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.
Infection and immunity 2008;76(1):229-38.
2007: Mark E Polhemus; Alan J Magill; James F Cummings; Kent Kester; Christian F Ockenhouse; David Lanar; Sheetij Dutta; Arnoldo Barbosa; Lorraine Soisson; Carter L Diggs; Sally A Robinson; J David Haynes; V Ann Stewart; Lisa A Ware; Clara Brando; Urszula Krzych; Robert A Bowden; Joe D Cohen; Marie-Claude Dubois; Opokua Ofori-Anyinam; Els De-Kock; W Ripley Ballou; Donald Heppner
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Vaccine 2007;25(21):4203-12.
2007: V Ann Stewart; Shannon M McGrath; Patrice M Dubois; Maria G Pau; Pascal Mettens; Joseph Shott; Michelle Cobb; J Robert Burge; David Larson; Lisa A Ware; Marie-Ange Demoitie; Gerrit Jan Weverling; Babak Bayat; Jerome H H V Custers; Marie-Claude Dubois; Joe Cohen; Jaap Goudsmit; Donald Heppner
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
Infection and immunity 2007;75(5):2283-90.
2007: Jose Stoute; Joash Gombe; Mark R Withers; Joram Siangla; Denise McKinney; Melanie Onyango; James F Cummings; Jessica Milman; Kathryn Tucker; Lorraine Soisson; V Ann Stewart; Jeffrey A Lyon; Evelina Angov; Amanda Leach; Joe Cohen; Kent Kester; Christian F Ockenhouse; Carolyn A Holland; Carter L Diggs; Janet Wittes; Donald Heppner
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
Vaccine 2007;25(1):176-84.
2006: V Ann Stewart; Douglas S Walsh; Shannon M McGrath; Kent Kester; James F Cummings; Gerald Voss; Martine Delchambre; Nathalie Garçon; Joe D Cohen; Donald Heppner
Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
Vaccine 2006;24(42-43):6493-502.
2006: V Ann Stewart; Shannon M McGrath; Douglas S Walsh; Stacey Davis; Aaron S Hess; Lisa A Ware; Kent Kester; James F Cummings; J Robert Burge; Gerald Voss; Martine Delchambre; Nathalie Garçon; Douglas B Tang; Joe D Cohen; Donald Heppner
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.
Vaccine 2006;24(42-43):6483-92.
2006: Douglas S Walsh; Montip Gettayacamin; Wolfgang W Leitner; Jeffrey A Lyon; V Ann Stewart; Gary Marit; Sathit Pichyangkul; Panita Gosi; Pongsri Tongtawe; Kent Kester; Carolyn A Holland; Nelly Kolodny; Joe Cohen; Gerald Voss; W Ripley Ballou; Donald Heppner
Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
Vaccine 2006;24(19):4167-78.
2006: Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Issaka Sagara; Alassane Dicko; David J Diemert; Donald Heppner; V Ann Stewart; Evelina Angov; Lorraine Soisson; Amanda Leach; Kathryn Tucker; Kirsten E Lyke; Christopher Plowe
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
PLoS clinical trials 2006;1(7):e34.
2006: Mark R Withers; Denise McKinney; Bernhards R Ogutu; John N Waitumbi; Jessica Milman; Odika J Apollo; Otieno G Allen; Kathryn Tucker; Lorraine Soisson; Carter L Diggs; Amanda Leach; Janet Wittes; Filip Dubovsky; V Ann Stewart; Shon A Remich; Joe Cohen; W Ripley Ballou; Carolyn A Holland; Jeffrey A Lyon; Evelina Angov; Jose Stoute; Samuel K Martin; Donald Heppner
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
PLoS clinical trials 2006;1(7):e32.
2005: In-Kyu Yoon; Evelina Angov; David Larson; Donald Heppner; James F Cummings; V Ann Stewart
Characterization of a human reference standard for antibody to Plasmodium falciparum merozoite surface protein 1(42).
The American journal of tropical medicine and hygiene 2005;72(6):714-8.
2004: Sathit Pichyangkul; Kosol Yongvanitchit; Utaiwan Kum-arb; Hiroaki Hemmi; Shizuo Akira; Arthur M Krieg; Donald Heppner; V Ann Stewart; Hitoshi Hasegawa; Sornchai Looareesuwan; G Dennis Shanks; R Scott Miller
Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(8):4926-33.
2003: V Ann Stewart
Plasmodium vivax under the microscope: the Aotus model.
Trends in parasitology 2003;19(12):589-94.
2001: Sathit Pichyangkul; P Saengkrai; Kosol Yongvanitchit; C Limsomwong; Montip Gettayacamin; Douglas S Walsh; V Ann Stewart; W Ripley Ballou; Donald Heppner
Isolation and characterization of rhesus blood dendritic cells using flow cytometry.
Journal of immunological methods 2001;252(1-2):15-23.